| Emel Bihorac, | |
|
2333 Ontario Rd Nw, Washington, DC 20009-2627 | |
| (202) 483-8196 | |
| Not Available |
| Full Name | Emel Bihorac |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2333 Ontario Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073223400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LGPC200001459 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emel Bihorac, 200 Florida Ave Ne Apt 1632, Washington, DC 20002-8152 Ph: (352) 870-8971 | Emel Bihorac, 2333 Ontario Rd Nw, Washington, DC 20009-2627 Ph: (202) 483-8196 |
News Archive
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three months ended March 31, 2010.
New research finds that children who were breastfed scored higher on neurocognitive tests. Researchers in the Del Monte Institute for Neuroscience at the University of Rochester Medical Center analyzed thousands of cognitive tests taken by nine and ten-year-olds whose mothers reported they were breastfed, and compared those results to scores of children who were not.
Cambridge Heart, Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Microvolt T-Wave Alternans (MTWA) OEM module. The MTWA OEM module is designed to work with existing cardiac stress test platforms distributed by other manufacturers. This FDA 510(k) clearance allows Cambridge Heart to begin marketing the MTWA OEM module integrated with the Q-Stress line of stress systems manufactured by Cardiac Science Corporation, Inc..
Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH). Nymox expects to report final results and statistical analysis for the study in the next 1-2 weeks. The new study concerns assessment of the 48-60 month efficacy and benefits of a single treatment of NX-1207.
Around half of all heterosexual men and women potentially carry so-called homosexuality genes that are passed on from one generation to the next. This has helped homosexuality to be present among humans throughout history and in all cultures, even though homosexual men normally do not have many descendants who can directly inherit their genes.
› Verified 7 days ago
Ms. Cassaundra Janiece Wilkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3861 Alabama Ave Se, Washington, DC 20020 Phone: 202-645-4488 Fax: 202-645-4590 | |
Ms. Pauline Imbrigato, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1012 14th St Nw, Suite 1025, Washington, DC 20005 Phone: 202-737-6000 Fax: 202-737-2332 | |
Giovanna Ysabela Dilauro, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1110 Lamont St Nw, Washington, DC 20010 Phone: 407-731-4581 | |
Joseph Martinez-williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Q St Ne, Washington, DC 20002 Phone: 202-674-2256 | |
Elyse Figueroa, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2812 Erie St Se Apt B34, Washington, DC 20020 Phone: 646-744-4458 | |
Melissa Cimino, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 915 Rhode Island Ave Nw, Washington, DC 20001 Phone: 202-232-6810 | |
Lili Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 441 21st St Ne, Washington, DC 20002 Phone: 202-341-6761 |